DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 1851 - 1875 of 62743 in total
Disease ID Disease Name Gene Symbol Gene ID ▲ Gene Name UniProt ID
C0025202 melanoma ST6GALNAC2 10610 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Q9UJ37
C0006826 Malignant Neoplasms ST6GALNAC2 10610 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Q9UJ37
C1458155 Mammary Neoplasms ST6GALNAC2 10610 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Q9UJ37
C0027651 Neoplasms ST6GALNAC2 10610 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Q9UJ37
C0017661 IGA Glomerulonephritis ST6GALNAC2 10610 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Q9UJ37
C0009402 Colorectal Carcinoma ST6GALNAC2 10610 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Q9UJ37
C0006142 Malignant neoplasm of breast ST6GALNAC2 10610 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Q9UJ37
C0678222 Breast Carcinoma ST6GALNAC2 10610 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Q9UJ37
C0206682 Follicular thyroid carcinoma ST6GALNAC2 10610 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Q9UJ37
C1269683 Major Depressive Disorder ST6GALNAC2 10610 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Q9UJ37
C1306459 Primary malignant neoplasm ST6GALNAC2 10610 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Q9UJ37
C0036341 Schizophrenia CSPG5 10675 chondroitin sulfate proteoglycan 5 O95196
C0175695 Sotos' syndrome CSPG5 10675 chondroitin sulfate proteoglycan 5 O95196
C0011311 Dengue Fever CSPG5 10675 chondroitin sulfate proteoglycan 5 O95196
C0018213 Graves Disease B3GNT2 10678 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 Q9NY97
C0265221 Walker-Warburg congenital muscular dystrophy B3GNT2 10678 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 Q9NY97
C0036341 Schizophrenia B3GNT2 10678 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 Q9NY97
C0027651 Neoplasms B3GNT2 10678 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 Q9NY97
C0027051 Myocardial Infarction B3GNT2 10678 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 Q9NY97
C0376358 Malignant neoplasm of prostate B3GNT2 10678 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 Q9NY97
C0033860 Psoriasis B3GNT2 10678 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 Q9NY97
C0007138 Carcinoma, Transitional Cell B3GNT2 10678 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 Q9NY97
C0027651 Neoplasms EBP 10682 EBP cholestenol delta-isomerase Q15125
C0029124 Optic Atrophy EBP 10682 EBP cholestenol delta-isomerase Q15125
C0023418 leukemia EBP 10682 EBP cholestenol delta-isomerase Q15125

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024